Schmieden, Germany

Doris Hubler


Average Co-Inventor Count = 6.8

ph-index = 2

Forward Citations = 82(Granted Patents)


Location History:

  • Schmieden, DE (1997 - 1999)
  • Scheiden, DE (1999)

Company Filing History:


Years Active: 1997-1999

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Doris Hubler: Innovator in Pharmaceutical Chemistry

Introduction

Doris Hubler is a notable inventor based in Schmieden, Germany. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of steroid compounds for various medical applications. With a total of three patents to her name, her work has had a profound impact on hormone therapy and treatment for specific medical conditions.

Latest Patents

Doris Hubler's latest patents include the development of 17.alpha.-cyanomethylestra-4,9-dien derivatives and pharmaceutical compositions. These compounds are designed for the treatment of endometriosis, gestagen-dependent tumors, and for hormonal contraception and climacteric hormone replacement therapy (HRT). The compounds are characterized by specific structural formulas, where R.sub.1 is an alkyl group with 1 to 2 carbon atoms, R.sub.2 is an alkyl or acyl group with 1 to 10 carbon atoms, and R.sub.3 can be an oxygen atom or a specific R--O--N group. Additionally, she has developed compound preparations for the treatment of hypogonadal men and those with hypophyseal diseases, utilizing both biogenous and synthetic androgens and estrogens. These preparations are available in various forms, including ointments, gels, sprays, and tablets, ensuring effective treatment for testosterone metabolism imbalances.

Career Highlights

Throughout her career, Doris Hubler has worked with reputable companies such as Jenapharm GmbH & Co. KG and Jenapharm GmbH. Her innovative work in pharmaceutical chemistry has led to advancements in hormone therapy, significantly improving treatment options for patients with hormonal imbalances.

Collaborations

Doris Hubler has collaborated with notable colleagues, including Michael Oettel and Michael Dittgen. These partnerships have contributed to her success in developing effective pharmaceutical solutions.

Conclusion

Doris Hubler's contributions to pharmaceutical chemistry and her innovative patents have made a lasting impact on the field. Her work continues to influence the development of treatments for hormonal imbalances and related medical conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…